Male Infertility Market, Male Infertility Market, By Test (DNA Fragmentation Technique, Oxidative, Stress Analysis, Microscopic Examination, Sperm Agglutination, Computer Assisted Semen Analysis, Sperm Penetration Assay and Others), By Technique (Assisted Reproductive Technology and Medication), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2034

Male Infertility Market was valued at US$ 4.4 Billion in 2024 and is projected to grow at a CAGR of 0.80%% to reach US$ 7.3 Billion by 2034.

Male Infertility is caused by major reason of low sperm production, chronic health problems, abnormal sperm blockages, injuries, illness and other factors which contribute in male infertility market growth. Male infertility causes inability to conceive a child which can be frustrating and stressful and number of treatments on male infertility are available in market.

Growing adoption of ART (assisted reproductive technologies) has become a major factor in target market growth. Rising prevalence of male infertility rate and new advanced technologies such as ICSI (Intra-cytoplasmic Sperm Injection), has revolutionized severe male infertility treatment which has provided lucrative opportunities in Male Infertility market growth.

Unhealthy lifestyle and rising male infertility rates to fuel the market growth

Growing unhealthy lifestyle such as consumption of poor nutrition food, irregular sleep patterns, stress is one of the leading factors for the Male Infertility Market growth. Urbanization has given rise in consumption of western food, unhealthy diet, unhealthy lifestyle, use of alcohol intake, cigarette smoking, lack of physical activity, obesity, use of illicit drugs which has become a fashion trend and in turn, facilitate the Male Infertility market growth.

According to PMC (PubMed Central), in March 2018, overweight and obesity associated with excessive fat accumulation determined using body mass index and a review of 30 studies comprised of 115 158 males were found that paternal obesity is associated with low male reproductive system and men with obese has higher percentage of sperm with abnormal morphology, DNA fragmentation, low mitochondrial membrane potential (MMP) and thus, likely to be more infertile.

According to PMC (PubMed Central), in 2015, the result concluded determines that around 30 million of men across globe are infertile were highest rates of infertility was observed in Eastern Europe and Africa.

Restrains:

However, high cost associated with treatment restrain the Male Infertility market growth.

 Male Infertility Market is segmented based on Test, Technique and Region.

Test Insight

On the basis of Type, Male Infertility Market is segmented into DNA Fragmentation Technique, Oxidative, Stress Analysis, Microscopic Examination, Sperm Agglutination, Computer Assisted Semen Analysis, Sperm Penetration Assay and Others. DNA Fragmentation Technique segment is expected to dominate the target market growth as it provides analysis of sperm DNA integrity with measuring amount of damaged DNA in a sample of sperm.

Technique Insights

On the basis of Technique, Male Infertility Market is segmented into Assisted Reproductive Technology and Medication. Assisted Reproductive Technology (ART) is expected to dominate the target market growth as it is widely used technique for treating male infertility that handles sperm and egg and allows control over time.

Regional Insights:

On region the Male Infertility Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The Europe market is estimated to witness a significantly high revenue share over the forecast period. Rising prevalence of male infertility rates, unhealthy diet & sedentary lifestyle, high disposable income, robust and well developed fertility clinics, adoption of advanced technology, high awareness about infertility, is anticipated to increase demand for Male Infertility in the region.

According to WWF (World Wide Fund For Nature), male infertility in Europe is rising due to man-made chemicals which has dropped sperm count in male, sperm that burn out before reaching egg. Further, the statistics data shown that one in five men in UK and around 40% of young men in Denmark has low sperm count and not able to become a father.

Further, growing British male infertility rates has given rise in treatment of ICSI (Intra-cytoplasmic Sperm Injection), where around 52% of fertility procedures were carried out across Europe in 2022, and more than 122,000 ICSIs performed in 2004.

Asia Pacific market is estimated to witness fastest growth rate due to rising prevalence of male infertility rates. Further, technological innovation in medical diagnostics is likely to propel Male Infertility market growth in region over the forecast period.

Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2022 to 2032. For the purpose of this study, has segmented the Male Infertility Market report based on Test, Technique and Region:

Male Infertility Market, By Test:

• DNA Fragmentation Technique
• Oxidative
• Stress Analysis
• Microscopic Examination
• Sperm Agglutination
• Computer Assisted Semen Analysis
• Sperm Penetration Assay
• Others

Male Infertility Market, By Technique:

• Assisted Reproductive Technology
• Medication

Male Infertility Market, By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating the Male Infertility Market includes, Zydus Lifesciences Ltd., Parallabs Ltd., European Sperm Bank, CooperSurgical, Inc., Cryolab Ltd., Irvine Scientific Sales Co., Inc., Halotech DNA, Microm Limited, Merck Serono SpA, ASKA Pharmaceutical, Inc., and others.

Recent Development:

• In March 2022, Prosterity Health launched new project “Access to care-Inclusion of the Male partner) AIM nationwide which help in providing men with at-home testing. It also provides access to male fertility specialists, where patient can use an at-home semen collection kit or can able to schedule semen analysis at RMA of New York andrology lab were men gets an opportunity to review the results and also process with male fertility consultation in fastest way.
• In November 2022, Sidra Medicine launched new Male Infertility Clinic in Qatar to expand its private reproductive medicine services. New launched clinic provides treatment of male infertility and also offers surgical & non-surgical treatments pertaining to sexual and erectile dysfunction, male urology and low libido & ejaculatory disorders.
• In June 2022, Oasis launched new male fertility clinic “Androlife” at Kompallt, Hyderabad (India). New launched clinic will cater male infertility issues with latest treatment such as Micro-TESE an advanced sperm retrieval procedure.

• Zydus Lifesciences Ltd.*
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies

• Parallabs Ltd.
• European Sperm Bank
• CooperSurgical, Inc.
• Cryolab Ltd.
• Irvine Scientific Sales Co., Inc.
• Halotech DNA
• Microm Limited
• Merck Serono SpA
• ASKA Pharmaceutical, Inc.

“*” marked represents similar segmentation in other categories in the respective section